Knight Therapeutics Inc KHTRF

Endo Files for Chapter 11

[MrMugsy]

Endo International has entered into a restructuring support agreement and filed for Chapter 11 proceedings in the Southern District of New York, according to a statement.

• Some Endo subsidiaries also filed for bankruptcy
  • Company’s India-based entities are not part of the proceedings
  • Expects to file recognition proceedings in Canada, UK and Australia

[CayoLelio]

Hola a todos. Os voy leyendo durante una temporada y servs de mucha ayuda con vuestro gran conocimiento de Knight. Yo tambin estoy en Knight desde hace un ao y sigo de cerca los avances de la empresa. Respecto a Endo me surgen varias reflexiones.  Desde luego sera un gran triunfo para Jonathan traer a Paladin de nuevo a casa, pero, ¿est Knight capacitada financieramente para

[CayoLelio]

(LO EDITO QUITANDO LA ORTOGRAFA DE ESPANOL) Hola a todos. Os voy leyendo durante una temporada y servis de mucha ayuda con vuestro gran conocimiento de Knight. Yo tambien estoy en Knight desde hace un year y sigo de cerca los avances de la empresa. Respecto a Endo me surgen varias reflexiones.  Desde luego sera un gran triunfo para Jonathan traer a Paladin de nuevo a casa, pero, ¿

[gudisgood]

Paladin Labs is not worth anywher close to $2B in its current form. From Endo's latest quarterly report, the International segment was flat y/y with YTD sales of $45M. So let's say the yearly sales are $90M... nobody's going to pay 22 times sales for Paladin (equal to paying $5.7 billion for today's version of Knight). If we look at Knight's biggest acquisitions: Knight paid

[MrMugsy]

As Samira said in the Q&A ... bankruptcy will be a long process. First we'll wait to see what happens to the company's assets and in who's hands they eventually fall.  Then you could have discussions about acquiring the international (Paladin) assets. If future Endo asset owners see little value putting energy into Paladin, then you might see some discussion.  It's

[gudisgood]

Yep! By the way, I had my Exelon numbers wrong (this is what happens when you write some of the numbers from memory instead of checking)... sorry! :) The price was actually $217M (CAD). In US dollars, it was $168M + $12M = $180M with $47M in sales... so 3.83x sales.

[MrMugsy]

Close enough Gudisgood. Your approach was right and in general, the numbers tell the story.  IMO. Paladin was sold for 5-6x sales (if not mistaken) and the reasons were likely ... 1.  high growth rate 2.  large potential to grow the structure - more geographies 3.  at peak of pharma cycle - high excitement and high valuations And ... We know Paladin has been stripped since

[Chianchin]

Paladin....paladin yet GUD gene got loost. Those who bougt Paladin are nearly bankrupt "over paid" Investors are longer foolls as back than. Mad mugsy stick with ATE a better lottery ticked to recover your monumental loses